| 000 | 01208 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250518003821.0 | ||
| 264 | 0 | _c20200311 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1744-8328 | ||
| 024 | 7 |
_a10.1080/14737140.2019.1537785 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFremd, Carlo | |
| 245 | 0 | 0 |
_aTargeted and immuno-biology driven treatment strategies for triple-negative breast cancer: current knowledge and future perspectives. _h[electronic resource] |
| 260 |
_bExpert review of anticancer therapy _c01 2019 |
||
| 300 |
_a29-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
| 700 | 1 | _aJaeger, Dirk | |
| 700 | 1 | _aSchneeweiss, Andreas | |
| 773 | 0 |
_tExpert review of anticancer therapy _gvol. 19 _gno. 1 _gp. 29-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14737140.2019.1537785 _zAvailable from publisher's website |
| 999 |
_c28969413 _d28969413 |
||